DaVita Q3 FY25: where the revenue came from and where it went
The whole income statement of DaVita for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2025
- Reported
- Oct 29, 2025
Revenue$3.42B
+5% year over year
Gross profit$0.92B
27% margin
Operating profit$0.51B
15% margin
Net profit$0.15B
4% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 3.42 | 100% | +5% |
| U.S.Dialysis & related lab | 2.97 | 87% | +3% |
| All other | 0.45 | 13% | +21% |
| Cost of revenue | −2.50 | 73% | |
| Gross profit | 0.92 | 27% margin | −2pp |
| G&A | −0.41 | 12% | +0pp |
| Operating profit | 0.51 | 15% margin | −2pp |
| Interest & other costs | −0.29 | ||
| Tax | −0.07 | ||
| Net profit | 0.15 | 4% margin | −2pp |
151 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest